Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma

Cancer Genetics

Volumn 204, Issue 3, 2011, Pages 138-146

  Maire, Georges ^a   Martin, Jeff W ^a   Yoshimoto, Maisa ^a   Chilton MacNeill, Susan ^b   Zielenska, Maria ^b   Squire, Jeremy A ^a,c  

^a QUEEN S UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Queen's Cancer Research Institute   (Canada)

Author keywords

Bioinformatics; MicroRNA; Oncogenesis; Osteosarcoma; Post transcriptional regulation

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NOTCH RECEPTOR; PROTEIN FOS; PROTEIN P21; RAS PROTEIN; WNT PROTEIN; MICRORNA;

ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; EPIGENETICS; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCUS; GENE MAPPING; GENE TARGETING; GENETIC ASSOCIATION; GENETIC CORRELATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; OSTEOSARCOMA; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; BIOSYNTHESIS; BONE TUMOR; COMPARATIVE GENOMIC HYBRIDIZATION; GENETICS; GENOMICS; HUMAN GENOME; METABOLISM;

BONE NEOPLASMS; COMPARATIVE GENOMIC HYBRIDIZATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; GENOMICS; HUMANS; MICRORNAS; OSTEOSARCOMA;

EID: 79960673180     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2010.12.012     Document Type: Article

References (59)

1. Bridge J.A., Nelson M., McComb E., et al. Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature. Cancer Genet Cytogenet 1997, 95:74-87.
2. Zielenska M., Bayani J., Pandita A., et al. Comparative genomic hybridization analysis identifies gains of 1p35 approximately p36 and chromosome 19 in osteosarcoma. Cancer Genet Cytogenet 2001, 130:14-21.
3. van Dartel M., Cornelissen P.W., Redeker S., et al. Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma. Cancer Genet Cytogenet 2002, 139:91-96.
4. Ozaki T., Neumann T., Wai D., et al. Chromosomal alterations in osteosarcoma cell lines revealed by comparative genomic hybridization and multicolor karyotyping. Cancer Genet Cytogenet 2003, 140:145-152.
5. Sandberg A.A., Bridge J.A. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer Genet Cytogenet 2003, 145:1-30.
6. Squire J.A., Pei J., Marrano P., et al. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays. Genes Chromosomes Cancer 2003, 38:215-225.
7. Lim G., Karaskova J., Vukovic B., et al. Combined spectral karyotyping, multicolor banding, and microarray comparative genomic hybridization analysis provides a detailed characterization of complex structural chromosomal rearrangements associated with gene amplification in the osteosarcoma cell line MG-63. Cancer Genet Cytogenet 2004, 153:158-164.
8. Man T.K., Lu X.Y., Jaeweon K., et al. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer 2004, 4:45.
9. Lim G., Karaskova J., Beheshti B., et al. An integrated mBAND and submegabase resolution tiling set (SMRT) CGH array analysis of focal amplification, microdeletions, and ladder structures consistent with breakage-fusion-bridge cycle events in osteosarcoma. Genes Chromosomes Cancer 2005, 42:392-403.
10. Selvarajah S., Yoshimoto M., Maire G., et al. Identification of cryptic microaberrations in osteosarcoma by high-definition oligonucleotide array comparative genomic hybridization. Cancer Genet Cytogenet 2007, 179:52-61.
11. Selvarajah S., Yoshimoto M., Ludkovski O., et al. Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH. Cytogenet Genome Res 2008, 122:5-15.
12. Clark J.C., Dass C.R., Choong P.F. A review of clinical and molecular prognostic factors in osteosarcoma. J Cancer Res Clin Oncol 2008, 134:281-297.
13. Sadikovic B., Yoshimoto M., Chilton-MacNeill S., et al. Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling. Hum Mol Genet 2009, 18:1962-1975.
14. Cleton-Jansen A.M., Anninga J.K., Briaire-de Bruijn I.H., et al. Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways. Br J Cancer 2009, 101:2064.
15. Kresse S.H., Ohnstad H.O., Paulsen E.B., et al. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization. Genes Chromosomes Cancer 2009, 48:679-693.
16. Maire G, Yoshimoto M, Chilton-MacNeill S, et al. Recurrent RECQL4 imbalance and increased gene expression levels are associated with structural chromosomal instability in sporadic osteosarcoma. Neoplasia 11:260-268 (263p following 268).
17. Pasic I., Shlien A., Durbin A.D., et al. Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res 2010, 70:160-171.
18. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat Rev Cancer 2006, 6:857-866.
19. Calin G.A., Garzon R., Cimmino A., et al. MicroRNAs and leukemias: how strong is the connection?. Leuk Res 2006, 30:653-655.
20. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269.
21. Subramanian S., Lui W.O., Lee C.H., et al. MicroRNA expression signature of human sarcomas. Oncogene 2008, 27:2015-2026.
22. He C., Xiong J., Xu X., et al. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples. Biochem Biophys Res Commun 2009, 388:35-40.
23. Song B., Wang Y., Xi Y., et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 2009, 28:4065-4074.
24. Jovanovic M., Hengartner M.O. miRNAs and apoptosis: RNAs to die for. Oncogene 2006, 25:6176-6187.
25. Babar I.A., Slack F.J., Weidhaas J.B. miRNA modulation of the cellular stress response. Future Oncol 2008, 4:289-298.
26. Lu J., Getz G., Miska E.A., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
27. Bayani J., Zielenska M., Pandita A., et al. Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas. Genes Chromosomes Cancer 2003, 36:7-16.
28. Sadikovic B., Thorner P., ChiltonMacNeill S., et al. Expression analysis of genes associated with human osteosarcoma tumors show correlation of RUNX2 overexpression with poor response to chemotherapy. BMC Cancer 2010, 10:202.
29. Schajowicz F., Sissons H.A., Sobin L.H. The World Health Organization's histologic classification of bone tumors. A commentary on the second edition. Cancer 1995, 75:1208-1214.
30. John B., Enright A.J., Aravin A., et al. Human MicroRNA targets. PLoS Biol 2004, 2:e363.
31. Cheng C., Li L.M. Inferring microRNA activities by combining gene expression with microRNA target prediction. PLoS One 2008, 3:e1989.
32. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
33. Krek A., Grun D., Poy M.N., et al. Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500.
34. Oliveros JC. VENNY. An interactive tool for comparing lists with Venn Diagrams. http://www.bioinfogp.cnb.csic.es/tools/venny/index.html.
35. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
36. Bussey K.J., Kane D., Sunshine M., et al. MatchMiner: a tool for batch navigation among gene and gene product identifiers. Genome Biol 2003, 4:R27.
37. Atiye J., Wolf M., Kaur S., et al. Gene amplifications in osteosarcoma-CGH microarray analysis. Genes Chromosomes Cancer 2005, 42:158-163.
38. Lu X.Y., Lu Y., Zhao Y.J., et al. Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma. Mol Cancer Res 2008, 6:937-946.
39. Kansara M., Thomas D.M. Molecular pathogenesis of osteosarcoma. DNA Cell Biol 2007, 26:1-18.
40. Ozaki T., Schaefer K.L., Wai D., et al. Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas. Int J Cancer 2002, 102:355-365.
41. Lau C.C., Harris C.P., Lu X.Y., et al. Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma. Genes Chromosomes Cancer 2004, 39:11-21.
42. Yen C.C., Chen W.M., Chen T.H., et al. Identification of chromosomal aberrations associated with disease progression and a novel 3q13.31 deletion involving LSAMP gene in osteosarcoma. Int J Oncol 2009, 35:775-788.
43. Entz-Werle N., Stoetzel C., Berard-Marec P., et al. Frequent genomic abnormalities at TWIST in human pediatric osteosarcomas. Int J Cancer 2005, 117:349-355.
44. Yan T., Wunder J.S., Gokgoz N., et al. COPS3 amplification and clinical outcome in osteosarcoma. Cancer 2007, 109:1870-1876.
45. Wang S., Aurora A.B., Johnson B.A., et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008, 15:261-271.
46. Liu B., Peng X.C., Zheng X.L., et al. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 2009, 66:169-175.
47. Zhu H., Wu H., Liu X., et al. Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 2008, 76:582-588.
48. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009, 10:704-714.
49. Li Z., Hassan M.Q., Volinia S., et al. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A 2008, 105:13906-13911.
50. Li H., Xie H., Liu W., et al. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest 2009, 119:3666-3677.
51. Huang J., Zhao L., Xing L., et al. MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 2010, 28:357-364.
52. Yang C., Yang S., Wood K.B., et al. Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45alpha expression. Apoptosis 2009, 14:124-133.
53. Al-Romaih K., Sadikovic B., Yoshimoto M., et al. Decitabine-induced demethylation of 5' CpG island in GADD45A leads to apoptosis in osteosarcoma cells. Neoplasia 2008, 10:471-480.
54. Syed N., Smith P., Sullivan A., et al. Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies. Blood 2006, 107:250-256.
55. Jacinto F.V., Ballestar E., Ropero S., et al. Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells. Cancer Res 2007, 67:11481-11486.
56. Pellegrino R., Calvisi D.F., Ladu S., et al. Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma. Hepatology 2010, 51:857-868.
57. Hu Z. Insight into microRNA regulation by analyzing the characteristics of their targets in humans. BMC Genomics 2009, 10:594.
58. Mercatelli N., Coppola V., Bonci D., et al. The inhibition of the highly expressed Mir-221 and Mir-222 impairs the growth of prostate carcinoma xenografts in mice. PLOS one 2009, 3:e4029.
59. Bonauer A, Carmona G, Iwasaki M, et al. MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice. Science 2009, 324:1710-1713.